[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-401875-105":59,"doc-detail-401875-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","truvada-fact-letter-2019","Truvada Fact Letter 2019","","October 2019 letter from the New York State Department of Health AIDS Institute addressing public concerns about Truvada and media advertisements about alleged harms. It explains Truvada’s FDA approval for HIV prevention (PrEP) and HIV treatment, references high-certainty guidance from the U.S. Preventive Services Task Force, and summarizes New York State clinical guideline support. The letter emphasizes adherence, routine monitoring, informed consent, and discussion of benefits, risks, side effects, and alternatives with care providers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/truvada-fact-letter-2019/401875/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/truvada-fact-letter-2019/401875.png","ImageObject",300,407,{"name":92,"@type":93},"mieayamfan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-27",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does the AIDS Institute address concerns about Truvada in this letter?","Question",{"text":112,"@type":113},"It responds to ongoing media advertisements promoting lawsuits that claim harm from taking Truvada, and addresses questions from individuals who have, are, or plan to take it, as well as concerns from care providers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What official approvals and recommendations are cited for Truvada?",{"text":117,"@type":113},"The letter states Truvada is FDA-approved for both HIV PrEP and HIV treatment. It also cites a U.S. Preventive Services Task Force Grade A recommendation for clinicians offering Truvada as PrEP to people at high risk.",{"name":119,"@type":110,"acceptedAnswer":120},"What responsibilities does the letter emphasize for safe and effective use?",{"text":121,"@type":113},"It stresses that high adherence is important, and that routine monitoring and laboratory testing by care providers are necessary to manage side effects and ensure prompt treatment of sexually transmitted infections.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},401875,1790665421,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":8,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":81,"preview_page_count":4},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","October, 2019  \nDear Colleagues and Community Members,  \nDue to ongoing media ads promoting lawsuits which claim harm to individuals from taking Truvada,(Tenofovirdisoproxil fumarate/emtricitabine) it is incumbent upon the New York State Department of Health AIDS Institute to respond to the concerns of individuals who have, are, or plan to take Truvada as well as any concerns that their care providers may have in prescribing Truvada.  \nThe AIDS Institute remains committed to our public health responsibility of promoting Truvada to help end the AIDS epidemic in New York State and to promote sexual health because:  \n• Truvada is a medication approved by the U.S. Food and Drug Administration for use both as HIV preexposure prophylaxis (PrEP) and treatment of HIV. The FDA Drug Approval Package can be found at [www.accessdata.fda.gov](www.accessdata.fda.gov).  \n• Based on its review of the evidence, the United States Preventative Services Task Force issued a Grade A recommendation (meaning there is high certainty that the net benefit is substantial) that clinicians offer Truvada as PrEP to persons who are at high risk of HIV acquisition. The evidence summary supporting this recommendation can be found [at](at www.uspreventiveservicestaskforce.org)[ ](at www.uspreventiveservicestaskforce.org)[www.uspreventiveservicestaskforce.org](at www.uspreventiveservicestaskforce.org).  \n• A committee of expert clinicians within New York State developed clinical guidelines, based on extensive reviews of medical literature and evidence, that strongly endorse the use of Truvada as:  \no an effective, evidence-based biomedical intervention for HIV (see “PrEP for HIV Prevention”), and  \no a safe and efficacious option for HIV treatment (see “Selecting an Initial ART Regimen”) .  \nWhen used as either HIV prevention or treatment, a high degree of adherence to Truvada is important on the part of the individual to ensure that the medication has a chance to work. Routine monitoring and laboratory testing are important on the part of the care provider to ensure any side effects are managed and to ensure prompt treatment of any sexually transmitted infections.  \nScientific evidence shows that when taken as directed, Truvada is safe and effective. Providers should always obtain informed consent before providing medical treatment. As there are risks to taking any medication, individuals should speak with their care provider about the benefits , risks (side effects), and possible alternatives for every medication they choose to take in order to understand the best choices for their specific situation.  \nThe AIDS Institute will continue to follow where medical science and research leads us. Our commitment to maintaining access to all safe and effective medications for all New Yorkers remains unwavering.  \nSincerely,  \nJohanne Morne  \nDirector, AIDS Institute  \nNew York State Department of Health  \nCharles John Gonzalez, M. D.  \nMedical Director, AIDS Institute New York State Department of Health  \nFor further reading, see:  \n[www.positivelyaware.com/articles/truvada-safety](www.positivelyaware.com/articles/truvada-safety)  \n[www.poz.com/article/behind-recent-media-ads-looking-plwh-people-taking-prep-side-effects-truvada](www.poz.com/article/behind-recent-media-ads-looking-plwh-people-taking-prep-side-effects-truvada)","cbCaisMO4ronos0p","https://ap.wps.com/l/cbCaisMO4ronos0p","pdf",132875,"English","# Response to concerns about Truvada\n## FDA approval and PrEP/Treatment uses\n## Evidence-based recommendations and guidelines\n## Adherence, monitoring, and informed consent\n## Continued commitment to safe access to medications","[{\"question\":\"Why does the AIDS Institute address concerns about Truvada in this letter?\",\"answer\":\"It responds to ongoing media advertisements promoting lawsuits that claim harm from taking Truvada, and addresses questions from individuals who have, are, or plan to take it, as well as concerns from care providers.\"},{\"question\":\"What official approvals and recommendations are cited for Truvada?\",\"answer\":\"The letter states Truvada is FDA-approved for both HIV PrEP and HIV treatment. It also cites a U.S. Preventive Services Task Force Grade A recommendation for clinicians offering Truvada as PrEP to people at high risk.\"},{\"question\":\"What responsibilities does the letter emphasize for safe and effective use?\",\"answer\":\"It stresses that high adherence is important, and that routine monitoring and laboratory testing by care providers are necessary to manage side effects and ensure prompt treatment of sexually transmitted infections.\"}]","Truvada Fact Letter 2019 | PDF",1790524787]